Call

+1 7755157689

A Rare Case of Successful Multiple Prolonged Runs of Extracorporeal Life Support for Severe Covid-19-Related Acute Respiratory Distress Syndrome

Editorial Extracorporeal life support (ECLS) is used worldwide as rescue therapy to manage severe COVID-19-related acute respiratory distress syndrome (ARDS). In patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO) for COVID- 19-related ARDS, the overall mortality rate is approximately 39%, and the mean ECMO duration (approximately 15 days) seems to be longer than that […]

Living longer and Living better

It was with great enthusiasm that we have seen the results published by Francis et al. concerning the adjuvant hormone therapy. In the SOFT study, the 8 year disease-free survival rate was 78.9% in patients who did only tamoxifen, 83.2% with tamoxifen and ovarian suppression, and 85.9% with exemestane and ovarian suppression

error: Content is protected !!